Metformin enhanced in vitro radiosensitivity associates with G2/M cell cycle arrest and elevated adenosine-5’-monophosphate-activated protein kinase levels in glioblastoma

Adeberg, Sebastian; Bernhardt, Denise; Harrabi, Semi B.; Nicolay, Nils H.; Hörner-Rieber, Juliane; König, Laila; Repka, Michael; Mohr, Angela; Abdollahi, Amir; Weber, Klaus-Josef; Debus, Juergen; Rieken, Stefan

doi:10.1515/raon-2017-0042

Abstract

Background

It is hypothesized that metabolism plays a strong role in cancer cell regulation. We have recently demonstrated improved progression-free survival in patients with glioblastoma who received metformin as an antidiabetic substance during chemoradiation. Although metformin is well-established in clinical use the influence of metformin in glioblastoma is far from being understood especially in combination with other treatment modalities such as radiation and temozolomide.

Materials and Methods

In this study, we examined the influence of metformin in combinations with radiation and temozolomide on cell survival (clonogenic survival), cell cycle (routine flow cytometric analysis, FACScan), and phosphorylated Adenosine-5’-monophosphate-activated protein kinase (AMPK) (Phopho-AMPKalpha1 - ELISA) levels in glioblastoma cell lines LN18 and LN229.

Results

Metformin and temozolomide enhanced the effectiveness of photon irradiation in glioblastoma cells. Cell toxicity was more pronounced in O⁶-methylguanine DNA methyltransferase (MGMT) promoter non-methylated LN18 cells. Induction of a G2/M phase cell cycle block through metformin and combined treatments was observed up to 72 h. These findings were associated with elevated levels of activated AMPK levels in LN229 cells but not in LN18 cells after irradiation, metformin, and temozolomide treatment.

Conclusions

Radiosensitizing effects of metformin on glioblastoma cells treated with irradiation and temozolomide in vitro coincided with G2/M arrest and changes in pAMPK levels.

References

Warburg O, Wind F, Negelein E. The metabolism of tumors in the Body. J Gen Physiol 1927; 8: 519-30.10.1085/jgp.8.6.519
Open DOI Search in Google Scholar Back to article
Warburg O. On the origin of cancer cells. Science 1956; 123: 309-14.10.1126/science.123.3191.30913298683
Open DOI Search in Google Scholar Back to article
Adeberg S, Bernhardt D, Harrabi SB, Bostel T, Mohr A, Koelsche C, et al. Metformin influences progression in diabetic glioblastoma patients. Strahlentherapie Onkol 2015; 191: 928-35. 10.1007/s00066-015-0884-5
Open DOI Search in Google Scholar Back to article
Goodarzi MO, Bryer-Ash M. Metformin revisited: re-evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents. Diabetes ObesMetab 2005; 7: 654-65. 10.1111/j.1463-1326.2004.00448
Open DOI Search in Google Scholar Back to article
Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001; 108: 1167-74. 10.1172/JCI1350511602624
Open DOI Search in Google Scholar Back to article
Sesen J, Dahan P, Scotland SJ, Saland E, Dang VT, Lemarie A, et al. Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response. PLoS One 2015; 10: e0123721. 10.1371/journal.pone.0123721
Open DOI Search in Google Scholar Back to article
Zannella VE, Cojocari D, Hilgendorf S, Vellanki RN, Chung S, Wouters BG, et al. AMPK regulates metabolism and survival in response to ionizing radiation. Radiother Oncol 2011; 99: 293-9. 10.1016/j.radonc.2011.05.04921715037
Open DOI Search in Google Scholar Back to article
Steinberg GR, Kemp BE. AMPK in health and disease. Physiol Review 2009; 89: 1025-78. 10.1152/physrev.00011.2008
Open DOI Search in Google Scholar Back to article
Jang T, Calaoagan JM, Kwon E, Samuelsson S, Recht L, Laderoute KR. 5'-AMP-activated protein kinase activity is elevated early during primary brain tumor development in the rat. Int J Cancer 2011; 128: 2230-9. 10.1002/ijc.2555820635388
Open DOI Search in Google Scholar Back to article
Park HU, Suy S, Danner M, Dailey V, Zhang Y, Li H, et al. AMP-activated protein kinase promotes human prostate cancer cell growth and survival. Mol Cancer Ther 2009; 8: 733-41. 10.1158/1535-716319372545
Open DOI Search in Google Scholar Back to article
Sanli T, Rashid A, Liu C, Harding S, Bristow RG, Cutz JC, et al. Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells. Int J Radiat Oncol Bool Phys 2010; 78: 221-9. 10.1016/j.ijrobp
Open DOI Search in Google Scholar Back to article
Zhang WB, Wang Z, Shu F, Jin YH, Liu HY, Wang QJ, et al. Activation of AMP-activated protein kinase by temozolomide contributes to apoptosis in glioblastoma cells via p53 activation and mTORC1 inhibition. J Biol Chem 2010; 285: 40461-71. 10.1074/jbc.M110.16404620880848
Open DOI Search in Google Scholar Back to article
Bischof M, Abdollahi A, Gong P, Stoffregen C, Lipson KE, Debus JU, et al. Triple combination of irradiation, chemotherapy (pemetrexed), and VEGFR inhibition (SU5416) in human endothelial and tumor cells. Int J Radiat OncolBiolPhys 2004; 60: 1220-32. 10.1016/j.ijrobp
Open DOI Search in Google Scholar Back to article
Combs SE, Bohl J, Elsasser T, Weber KJ, Schulz-Ertner D, Debus J, et al. Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines. Int J Radiat Biol 2009; 85: 126-37. 10.1080/0955300080264115119280465
Open DOI Search in Google Scholar Back to article
Liu X, Chhipa RR, Pooya S, Wortman M, Yachyshin S, Chow LM, et al. Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK. Proc Natl Acad Sci U S A 2014; 111: E435-44. 10.1073/pnas.131112111124474794
Open DOI Search in Google Scholar Back to article
Wurth R, Pattarozzi A, Gatti M, Bajetto A, Corsaro A, Parodi A, et al. Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt. Cell Cycle 2013; 12: 145-56. 10.4161/cc.2305023255107
Open DOI Search in Google Scholar Back to article
Janjetovic K, Harhaji-Trajkovic L, Misirkic-Marjanovic M, Vucicevic L, Stevanovic D, Zogovic N, et al. In vitro and in vivo anti-melanoma action of metformin. Eur J Pharmacol 2011; 668: 373-82. 10.1016/j.ejphar21806981
Open DOI Search in Google Scholar Back to article
Scotland S, Saland E, Skuli N, de Toni F, Boutzen H, Micklow E, et al. Mitochondrial energetic and AKT status mediate metabolic effects and apoptosis of metformin in human leukemic cells. Leukemia 2013; 27: 212938. 10.1038/leu
Open DOI Search in Google Scholar Back to article
Feng Y, Ke C, Tang Q, Dong H, Zheng X, Lin W, et al. Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by down-regulating Stat3 signaling. Cell Death Dis 2014; 5: e1088. 10.1038/cddis
Open DOI Search in Google Scholar Back to article
Tomic T, Botton T, Cerezo M, Robert G, Luciano F, Puissant A, et al. Metformin inhibits melanoma development through autophagy and apoptosis mechanisms. Cell Death Dis 2011; 2: e199. 10.1038/cddis
Open DOI Search in Google Scholar Back to article
Taghian A, Suit H, Pardo F, Gioioso D, Tomkinson K, DuBois W, et al. In vitro intrinsic radiation sensitivity of glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1992; 23: 55-62.10.1016/0360-3016(92)90543-Q1315313
Open DOI Search in Google Scholar Back to article
Harrabi S, Combs SE, Brons S, Haberer T, Debus J, Weber KJ. Temozolomide in combination with carbon ion or photon irradiation in glioblastoma multiforme cell lines - does scheduling matter? Int J Radiat Biol 2013; 89: 692-7. 10.3109/0955300223577964
Open DOI Search in Google Scholar Back to article
Yu Z, Zhao G, Li P, Li Y, Zhou G, Chen Y, et al. Temozolomide in combination with metformin act synergistically to inhibit proliferation and expansion of glioma stem-like cells. Oncol Lett 2016; 11: 2792-800. 10.3892/ol.2016.431527073554
Open DOI Search in Google Scholar Back to article
Shi WY, Xiao D, Wang L, Dong LH, Yan ZX, Shen ZX, et al. Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy. Cell Death Dis 2012; 3: e275. 10.1038/cddis
Open DOI Search in Google Scholar Back to article
Zheng B, Jeong JH, Asara JM, Yuan YY, Granter SR, Chin L, et al. Oncogenic B-RAF negatively regulates the tumor suppressor LKB1 to promote melanoma cell proliferation. Mol Cell 2009; 33: 237-47. 10.1016/j.molcel.2008.12.02619187764
Open DOI Search in Google Scholar Back to article
Rios M, Foretz M, Viollet B, Prieto A, Fraga M, Costoya JA, et al. AMPK activation by oncogenesis is required to maintain cancer cell proliferation in astrocytic tumors. Cancer Res 2013; 73: 2628-38. 10.1158/0008-547223370326
Open DOI Search in Google Scholar Back to article
Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, Makela TP, et al. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2003; 2: 28. 10.1186/1475-4924-2-2814511394
Open DOI Search in Google Scholar Back to article
Shaw RJ, Kosmatka M, Bardeesy N, Hurley RL, Witters LA, DePinho RA, et al. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci U SA 2004; 101: 3329-35.10.1073/pnas.030806110014985505
Open DOI Search in Google Scholar Back to article
Woods A, Johnstone SR, Dickerson K, Leiper FC, Fryer LG, Neumann D, et al. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol 2003; 13: 2004-8.1461482810.1016/j.cub.2003.10.031
Open DOI Search in Google Scholar Back to article
Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, Xu Y, et al. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell 2005; 18: 283-93. 10.1016/j.molcel15866171
Open DOI Search in Google Scholar Back to article
Fogarty S, Hardie DG. Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer. Biochim Biophys Acta 2010; 1804: 581-91. 10.1016/j.bbapap19778642
Open DOI Search in Google Scholar Back to article
Guo D, Cloughesy TF, Radu CG, Mischel PS. AMPK: A metabolic checkpoint that regulates the growth of EGFR activated glioblastomas. Cell Cycle 2010; 9: 211-2. 10.4161/cc20023392
Open DOI Search in Google Scholar Back to article
Isakovic A, Harhaji L, Stevanovic D, Markovic Z, Sumarac-Dumanovic M, Starcevic V, et al. Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis. Cell Mol Life Sci 2007; 64: 1290-302. 10.1007/s00018-007-7080-417447005
Open DOI Search in Google Scholar Back to article
Kisfalvi K, Eibl G, Sinnett-Smith J, Rozengurt E. Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth. Cancer Res 2009; 69: 6539-45. 10.1158/0008-5472.CAN-09-041819679549
Open DOI Search in Google Scholar Back to article
Sato A, Sunayama J, Okada M, Watanabe E, Seino S, Shibuya K, et al. Gliomainitiating cell elimination by metformin activation of FOXO3 via AMPK. Stem Cell Trans Med 2012; 1: 811-24. 10.5966/sctm.2012-0058
Open DOI Search in Google Scholar Back to article